Press coverage about Core Laboratories N.V. (NYSE:CLB) has been trending somewhat positive on Wednesday, Accern reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Core Laboratories N.V. earned a news impact score of 0.13 on Accern’s scale. Accern also gave news stories about the oil and gas company an impact score of 46.2924933516148 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

A number of equities analysts recently commented on CLB shares. ValuEngine downgraded Core Laboratories N.V. from a “hold” rating to a “sell” rating in a report on Friday, September 1st. Royal Bank Of Canada cut their price target on shares of Core Laboratories N.V. from $115.00 to $112.00 and set an “outperform” rating on the stock in a report on Thursday, September 7th. Zacks Investment Research cut shares of Core Laboratories N.V. from a “buy” rating to a “hold” rating in a report on Friday, June 23rd. Credit Suisse Group raised shares of Core Laboratories N.V. from a “neutral” rating to an “outperform” rating and set a $110.00 price objective on the stock in a research report on Thursday, August 24th. They noted that the move was a valuation call. Finally, Cowen and Company reissued a “hold” rating and set a $100.00 price objective on shares of Core Laboratories N.V. in a research report on Friday, September 1st. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $113.58.

Core Laboratories N.V. (NYSE:CLB) opened at 97.53 on Wednesday. The stock has a market capitalization of $4.30 billion, a PE ratio of 59.83 and a beta of 1.63. The company’s 50-day moving average is $93.04 and its 200-day moving average is $102.97. Core Laboratories N.V. has a 12 month low of $86.55 and a 12 month high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last issued its earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. The business had revenue of $163.90 million during the quarter, compared to analysts’ expectations of $168.23 million. During the same period in the prior year, the business earned $0.35 EPS. The business’s revenue for the quarter was up 10.7% compared to the same quarter last year. Equities research analysts forecast that Core Laboratories N.V. will post $1.99 EPS for the current year.

WARNING: “Core Laboratories N.V. (CLB) Receives Daily Coverage Optimism Rating of 0.13” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Insider Buying and Selling by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.